Click below to access the solution brief
People often use social media to share their health-related experiences and unwanted side effects of pharmaceutical products they use. In fact, 83% report they would be more inclined to report suspected adverse drug reactions (ADRs) via social media if they were welcomed into the conversation and felt that their feedback was important.
Today's pharmaceutical and biotechnology companies are quickly growing their social media presence. In this new realm, Managing the chatter and feedback about your products is important. You must monitor for ADRs and ensure your social content adheres to regulatory requirements.
Download the solution brief to learn more.